Is SARS‐CoV‐2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody‐based therapeutics?
Journal article published in 2021 by
Daniele Focosi 
,
Massimo Franchini,
Liise‐anne Pirofski,
Fabrizio Maggi,
Arturo Casadevall
,
Massimo Franchini,
Liise‐anne Pirofski,
Fabrizio Maggi,
Arturo Casadevall
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 